18F-FDG PET and PET/CT for the evaluation of gastric signet ring cell carcinoma: a systematic review
- PMID: 34456317
- PMCID: PMC9897274
- DOI: 10.1097/MNM.0000000000001481
18F-FDG PET and PET/CT for the evaluation of gastric signet ring cell carcinoma: a systematic review
Abstract
Background: In the last years, 18F-fluorodeoxyglucose PET/computed tomography (18F-FDG PET/CT) has demonstrated its utility for the evaluation of gastric cancer; however, considering some histotypes such as gastric signet ring cell carcinoma (GSRCC) the results are limited. The aim of this review is to analyze the diagnostic performance of 18F-FDG PET and PET/CT for the assessment of GSRCC.
Methods: A wide literature search of the PubMed/MEDLINE, Scopus, Embase and Cochrane library databases was made to find relevant published articles about the diagnostic performance of 18F-FDG PET or PET/CT for the evaluation of GSRCC.
Results: The comprehensive computer literature search revealed 179 articles. On reviewing the titles and abstracts, 162 articles were excluded because the reported data were not within the field of interest. Nine studies were included in the review and references were also screened for additional articles. Finally, 26 articles were selected and retrieved in full-text version.
Conclusion: Despite some limitations affect our review, GSRCC seems to have low 18F-FDG uptake, and therefore 18F-FDG PET or PET/CT reveals impaired sensitivity for its evaluation. However, a correlation between 18F-FDG uptake and some clinico-pathologic features (such as stage, depth of invasion, size and presence of nodal metastasis) has been demonstrated. Besides, a possible prognostic role of PET/CT features is starting to emerge.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Figures
Similar articles
-
18F-fluorodeoxyglucose PET and PET/computed tomography for the evaluation of immunoglobulin G4-related disease: a systematic review.Nucl Med Commun. 2022 Jun 1;43(6):638-645. doi: 10.1097/MNM.0000000000001566. Epub 2022 Apr 19. Nucl Med Commun. 2022. PMID: 35438679
-
Widespread Metastatic Gastric Signet-Ring Cell Carcinoma Shown by 68Ga-FAPI PET/CT.Clin Nucl Med. 2021 Feb 1;46(2):e78-e79. doi: 10.1097/RLU.0000000000003245. Clin Nucl Med. 2021. PMID: 32804764
-
18F-FDG PET/CT for the evaluation of male breast cancer: a systematic review.Nucl Med Commun. 2022 Feb 1;43(2):123-128. doi: 10.1097/MNM.0000000000001508. Nucl Med Commun. 2022. PMID: 34783719
-
[Malignant tumor with false negative 18F-FDG PET image].Zhonghua Zhong Liu Za Zhi. 2006 Sep;28(9):713-7. Zhonghua Zhong Liu Za Zhi. 2006. PMID: 17274383 Chinese.
-
18F-FDG PET or PET/CT role in plasmacytoma: A systematic review.Rev Esp Med Nucl Imagen Mol (Engl Ed). 2020 Jul-Aug;39(4):220-224. doi: 10.1016/j.remn.2019.12.004. Epub 2020 Jun 7. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2020. PMID: 32522411 English, Spanish.
Cited by
-
Selecting Targets for Molecular Imaging of Gastric Cancer: An Immunohistochemical Evaluation.Mol Diagn Ther. 2025 Mar;29(2):213-227. doi: 10.1007/s40291-024-00755-5. Epub 2024 Nov 14. Mol Diagn Ther. 2025. PMID: 39541080 Free PMC article.
-
Identifying the primary tumour in patients with cancer of unknown primary (CUP) using [18F]FDG PET/CT: a systematic review and individual patient data meta-analysis.Eur J Nucl Med Mol Imaging. 2024 Dec;52(1):225-236. doi: 10.1007/s00259-024-06860-1. Epub 2024 Aug 14. Eur J Nucl Med Mol Imaging. 2024. PMID: 39141069 Free PMC article.
-
A narrative review on rare types of pancreatic cancer: should they be treated as pancreatic ductal adenocarcinomas?Ther Adv Med Oncol. 2024 Jul 26;16:17588359241265213. doi: 10.1177/17588359241265213. eCollection 2024. Ther Adv Med Oncol. 2024. PMID: 39072242 Free PMC article. Review.
-
PET/CT and Conventional Imaging for the Assessment of Neuroendocrine Prostate Cancer: A Systematic Review.Cancers (Basel). 2023 Sep 3;15(17):4404. doi: 10.3390/cancers15174404. Cancers (Basel). 2023. PMID: 37686680 Free PMC article. Review.
-
Unexpected focal fluorodeoxyglucose uptake in main organs; pass through or pass by?World J Clin Cases. 2024 Apr 16;12(11):1885-1899. doi: 10.12998/wjcc.v12.i11.1885. World J Clin Cases. 2024. PMID: 38660550 Free PMC article. Review.
References
-
- Kaneko Y, Murray WK, Link E, Hicks RJ, Duong C. Improving patient selection for 18F-FDG PET scanning in the staging of gastric cancer. J Nucl Med. 2015; 56:523–529. - PubMed
-
- Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol. 2006; 24:2137–2150. - PubMed
-
- Kunisaki C, Makino H, Akiyama H, Otsuka Y, Ono HA, Kosaka T, et al. . Clinical significance of the metastatic lymph-node ratio in early gastric cancer. J Gastrointest Surg. 2008; 12:542–549. - PubMed
-
- Bilici A, Ustaalioglu BB, Seker M, Kefeli U, Canpolat N, Tekinsoy B, et al. . The role of 18F-FDG PET/CT in the assessment of suspected recurrent gastric cancer after initial surgical resection: can the results of FDG PET/CT influence patients’ treatment decision making? Eur J Nucl Med Mol Imaging. 2011; 38:64–73. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical